On this week’s Tech Nation, Moira speaks with GUY KAWASAKI – for a second time this year! He’s back with the ten year-update on his classic book THE ART OF THE START 2.0. The time-tested battled-hardened guide for anyone starting anything.

Then on BioTech Nation, it’s RACHEL KING and Glycomimetics – they’ve found success in Sickle Cell Disease, and now they’re working on AML –Acute Myeloid Leukemia, especially in patients over 60.

On this week’s Tech Nation, Moira speaks with DR CHARLOTTE JACOBS, professor emirata at Stanford University School of Medicine and the author of “Jonas Salk: A Life”. They re-visit 1950’s America under the threat of Polio. What did science know and what did it gotten wrong?

Then on BioTech Nation, JAY LICHTER of Avalon Ventures tells us about his diagnosis of Meniere's disease, and how as a venture capitalist he decided to start a company to find better treatment options on the spot. The result is the company called Otonomy.

On this episode Tech Nation broadcasts from BIO 2015, the international biotechnology conference in Philadelphia. The buzz centers around a new focus on patient-oriented drug development, as well as real success with cancer immunotherapies and deep progress in rare diseases. There are signs that the industry is maturing, finally delivering on the promise of bio-pharmaceutical drugs on an unprecedented scale, while the effect of patents on emerging products is a concern, as getting drugs to humans is different than patenting a widget.

Dr. Moira Gunn speaks with:
- JIM GREENWOOD President and CEO of BIO, the Biotechnology Industry Organization as Tech Nation
- PAUL HASTINGS Chairman and President, OncoMed Pharmaceuticals and Chairnman, BIO Board of Directors’ Patient Advocacy Committee
MIKE MAY, Editorial Director of Scientific American WorldView and YALI FRIEDMAN is the head of data analytics for Scientific American WorldView, and
- GARETH WILLIAMS Partner and Patent Attorney, Marks & Clerk International Intellectual Property Firm and Editor-in-Chief, Marks & Clerk Life Sciences Report 2015 “From Rare to Routine: Medicines for Rare Diseases, Vaccines & Antibiotics.”

On this week’s Tech Nation, Moira speaks with Stanford’s DR. TINA SEELIG about her book “INSIGHT OUTSIGHT OUT: Get Ideas Out of your Head and into the World.” We'll find out the difference between imagination, creativity, and innovation.

Then on BioTech Nation, it’s all about “wearables” – personal technology we can strap on our wrists, or our bodies that can help you and your doctor monitor your health. DR. DANIEL KRAFT is the Chair of Medicine at Singularity University and the Founder of Exponential Medicine. We'll hear what's coming and what it means for all of us.

On this week’s Tech Nation, Moira speaks with

LEEROM SEGAL, President & CEO, Klick Health and the author of “The Decoded Company.” With all the information everyone access to and generates all the time, it turns out that the ecosystem of a company is more important than its organization chart.

Then on BioTech Nation, we discuss decoding a whole human genome, and doing it fast with PIETER VAN ROOYEN, President & CEO of Edico Genome.

Then we'll discuss the role of voluntary patient registries to better treat long term chronic disease, such as heart disease and Rheumatoid Arthritis with DR. STEFAN LARSSON, Partner, Boston Consulting Group, Stockholm and Dr. DR. SOFIA ERNESTAM, Senior Physician in Rheumatology, Karolinska Institute

On this week’s Tech Nation, Moira speaks with DAN MOTE, the President of the National Academy of Engineering. They talk about the difference between technology and engineering.

Then on BioTech Nation, SIR JOHN CHISHOLM, head of Genomics England and the 100,000 Genomes Project

On this week’s Tech Nation, Moira speaks with GEOFF MOORE, Strategy Consultant
Author, “CROSSING THE CHASM: Marketing and Selling Disruptive Products to Mainstream Customers, third edition” about what happens to a hot tech companies that get a lot of interest early … and then never make it.

Then on BioTech Nation, ANNE WOJCICKI, the co-founder and CEO of 23andMe. From DNA analysis and a new grant from the National Institutes of Health to a new partnership with Pfizer on Crohn's Disease, there's more to 23andMe than meets the eye.

On this week’s Tech Nation, Moira speaks with DR. BESSEL VAN DER KOLK, the founder and medical director of the Trauma Center in Boston, and a professor at psychiatry at Boston University Medical Center. He’s written “The Body Keeps the Score: Brain, Mind and Body in the Healing of Trauma.” #medecine #braintrauma #science

Then on BioTech Nation, we talk to MARTIN McGLYNN, President & CEO, StemCells, Inc. about initial attempts at stem cell treatments for such different conditions as spinal cord injury, PMD (Pelizaeus Merzbacher Disease) and age-related macular degeneration begin to show promise. #spinalcordinjury #pmd #stemcells #health

On this week’s Tech Nation, Moira speaks with
McGill professor and behavioral neuroscientist DANIEL LEVITIN about “The Organized Mind: Thinking Straight in the Age of Information Overload.” Our brains need to operate differently today than they ever did before.

Then on BioTech Nation, “The most important genome in your body may not be your own.” So says MOHAN IYER, the Chief Business Officer of Second Genome. We talk about our microbiomes – the trillions of microbes which populate our bodies, as well as the impact they may have on us.

On this week’s Tech Nation, Moira speaks with
a panel of esteemed professors, who will explain each of the 2014 Nobel prizes, and why they are important.

These include:
GENARO PADILLA
English Professor
UC Berkeley,

STEPHEN ZUNES
Politics Professor
University of San Francisco,

JOE FARRELL
Economics Professor
UC Berkeley,

CONNIE CHANG
Electrical Engineering and Computer Sciences Professor
UC Berkeley,

Jai Yu
Neuroscientist
UC San Francisco
Center for Integrative Neuroscience